IOH-006

N/A

Report date: 2025/06/11 10:26:48

Base Information

Drug NameIOH-006
Drug Alias Nameanti-CD47 bispecific antibody (ImmuneOncia Therapeutics/Y-Biologics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionCluster of differentiation 47 inhibitorsImmunostimulantsMacrophages stimulants
TargetsCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuneoncia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmuneoncia Therapeutics IncY-biologics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A